LifeMD, Inc. Shareholder Notice Regarding Lead Plaintiff Deadline
Attention shareholders of LifeMD, Inc. (NASDAQ: LFMD)! There is an important lead plaintiff deadline set for October 25, 2025. Shareholders who acquired shares of LFMD during the noted class period are encouraged to seek potential recognition as a lead plaintiff.
Understanding the Class Period and Allegations
The class period for the allegations spans from May 7, 2025, until August 5, 2025. The complaint suggests that during this timeframe, serious issues arose concerning the accuracy of LifeMD's operational disclosures. Specifically, it claims that the defendants provided significantly misleading information about the company’s position in the market.
The allegations state that LifeMD's guidance for 2025 was overly ambitious, failing to account for crucial factors like rising costs associated with customer acquisition in various segments of their business. This includes products aimed at treating obesity which did not align with reality, creating a situation of inflated expectations and misleading perspectives regarding LifeMD's prospects.
What Should Shareholders Do?
For shareholders of LifeMD, it is crucial to act promptly. Signing up as a lead plaintiff is not a requirement for participating in any potential recovery, but it can be a proactive step. Registering will also place shareholders into a monitoring program that keeps them informed on case developments.
Key Deadlines and Next Steps
The key date to remember is October 25, 2025. This is your final opportunity to register your interest in joining the action. There's no need for hesitation, as registration is simple and comes at no cost. By doing so, you can ensure that your voice is heard in this significant matter.
After signing up, shareholders will receive continual updates through a dedicated monitoring platform. This will ensure that you are informed of all pertinent actions taken regarding your investment in LifeMD as the case progresses.
Why Choose the Gross Law Firm?
The Gross Law Firm is dedicated to safeguarding the rights of investors like you who may have suffered losses due to misrepresentation and fraudulent practices in business. Their mission is clear: to advocate rigorously for shareholders who have endured impacts as a result of deceitful corporate behaviors.
With a commitment to ensuring that companies engage in ethical and responsible business conduct, they strive to restore losses incurred when misleading statements artificially inflated stock values. By trusting in their expertise, you are aligning yourself with a firm focused on fairness and diligence in the pursuit of justice.
Contact Information for Inquiries
If you need further information or assistance regarding your participation in this class action, you may contact The Gross Law Firm directly. They are conveniently located at:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY 10018
Phone: (646) 453-8903
Frequently Asked Questions
What is the lead plaintiff deadline for LifeMD, Inc.?
The lead plaintiff deadline is October 25, 2025, for shareholders of LifeMD, Inc. to register their interest.
How do I register as a shareholder?
Shareholders can register by providing their information through the offered forms without any cost or obligation.
What are the allegations against LifeMD, Inc.?
The allegations include the issuance of materially false statements regarding LifeMD's market position and financial guidance during a specific timeframe.
Is there a fee to participate in the class action?
No, there is no fee or obligation for shareholders to participate in the class action.
Why should I choose The Gross Law Firm?
The Gross Law Firm is recognized for its commitment to protecting shareholder rights and holding companies accountable for misleading practices.
